Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Alpendurada, Francisco ^a   Guha, Kaushik ^a   Sharma, Rakesh ^a   Ismail, Tevfik F ^a   Clifford, Amy ^a   Banya, Winston ^a   Mohiaddin, Raad H ^a   Pennell, Dudley J ^a   Cowie, Martin R ^a   McDonagh, Theresa ^b   Prasad, Sanjay K ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

cardiac resynchronization therapy; cardiovascular magnetic resonance; heart failure; right ventricular function

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOBUTROL; GADOLINIUM; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; WARFARIN;

AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TRICUSPID VALVE; HEART LEFT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONDON; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84857673886     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-68     Document Type: Article

References (33)

1. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, N Engl J Med 2001 344 873 80 10.1056/NEJM200103223441202 11259720 (Pubitemid 32224395)
2. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, N Engl J Med 2005 352 1539 1549 10.1056/NEJMoa050496 15753115 (Pubitemid 40517094)
3. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Epstein AE, Dimarco JP, Ellenbogen KA, et al. Heart Rhythm 2008 5 934 955 10.1016/j.hrthm.2008.04.015 18534377
4. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. Field ME, Solomon SD, Lewis EF, Kramer DB, Baughman KL, Stevenson LW, Tedrow UB, J Card Fail 2006 12 616 620 10.1016/j.cardfail.2006.06. 472 17045180 (Pubitemid 44512147)
5. Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy. Scuteri L, Rordorf R, Marsan NA, Landolina M, Magrini G, Klersy C, Frattini F, Petracci B, Vicentini A, Campana C, Tavazzi L, Ghio S, Pacing Clin Electrophysiol 2009 32 1040 1049 10.1111/j.1540-8159.2009.02436.x 19659624
6. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A, Cleland JG, Tavazzi L, Eur J Heart Fail 2009 11 480 488 10.1093/eurjhf/hfp034 19287017
7. Right ventricular systolic function and cardiac resynchronization therapy. Burri H, Domenichini G, Sunthorn H, Fleury E, Stettler C, Foulkes I, Shah D, Europace 2010 12 389 394 10.1093/europace/eup401 19966321
8. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2005 7 775 782 10.1080/10976640500295516 16353438 (Pubitemid 41770055)
9. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. Maceira AM, Prasad SK, Khan M, Pennell DJ, J Cardiovasc Magn Reson 2006 8 417 426 10.1080/ 10976640600572889 16755827
10. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Maceira AM, Prasad SK, Khan M, Pennell DJ, Eur Heart J 2006 27 2879 2888 10.1093/eurheartj/ehl336 17088316 (Pubitemid 44871471)
11. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK, J Am Coll Cardiol 2010 56 867 74 10.1016/j.jacc.2010.05.010 20688032
12. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ, Am J Cardiol 2003 92 1238 1240 10.1016/j.amjcard.2003.06.016 14609610 (Pubitemid 37377846)
13. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Bleeker GB, Bax JJ, Fung JW, van der Wall EE, Zhang Q, Schalij MJ, Chan JY, Yu CM, Am J Cardiol 2006 97 260 263 10.1016/j.amjcard.2005.08.030 16442375 (Pubitemid 43139248)
14. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Santamore WP, Dell'Italia LJ, Prog Cardiovasc Dis 1998 40 289 308 10.1016/S0033-0620(98)80049-2 9449956 (Pubitemid 28060410)
15. Assessment of right ventricular function using two-dimensional echocardiography. Kaul S, Tei C, Hopkins JM, Shah PM, Am Heart J 1984 107 526 531 10.1016/0002-8703(84)90095-4 6695697 (Pubitemid 14167729)
16. Inter- and intra-observer variability in the echocardiographic evaluation of right ventricular function. Pinedo M, Villacorta E, Tapia C, Arnold R, Lápez J, Revilla A, Gámez I, Fulquet E, San Román JA, Rev Esp Cardiol 2010 63 802 809 20609314
17. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, Campana C, Gavazzi A, Tavazzi L, Am J Cardiol 2000 85 837 842 10.1016/S0002-9149(99)00877-2 10758923 (Pubitemid 30157849)
18. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy. Tedrow UB, Kramer DB, Stevenson LW, Stevenson WG, Baughman KL, Epstein LM, Lewis EF, Am J Cardiol 2006 97 1737 40 10.1016/j.amjcard.2006.01.033 16765124 (Pubitemid 43817860)
19. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM, Lancet 2003 361 374 9 10.1016/S0140-6736(03)12389-6 12573373 (Pubitemid 36164969)
20. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, van der Wall EE, Schalij MJ, Bax JJ, Circulation 2006 113 969 76 10.1161/CIRCULATIONAHA.105.543678 16476852 (Pubitemid 43879472)
21. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ, van der Wall EE, Bax JJ, Am J Cardiol 2007 99 657 660 10.1016/j.amjcard.2006.09.115 17317367
22. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, Klein G, Drangova M, J Am Coll Cardiol 2006 48 1953 1960 10.1016/j.jacc.2006.07.046 17112984 (Pubitemid 44738444)
23. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Chalil S, Foley PW, Muyhaldeen SA, Patel KC, Yousef ZR, Smith RE, Frenneaux MP, Leyva F, Europace 2007 9 1031 1037 10.1093/europace/eum133 17933857 (Pubitemid 351773274)
24. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Marsan NA, Westenberg JJ, Ypenburg C, van Bommel RJ, Roes S, Delgado V, Tops LF, van der Geest RJ, Boersma E, de Roos A, Schalij MJ, Bax JJ, Eur Heart J 2009 30 2360 7 10.1093/eurheartj/ehp280 19578165
25. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A, J Cardiovasc Magn Reson 2011 13 29 10.1186/1532-429X-13-29 21668964
26. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB, J Interv Card Electrophysiol 2005 12 107 113 10.1007/s10840-005-6545-3 15744462 (Pubitemid 40386293)
27. Difference in long-term clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure. Zhang Q, Fung JW, Chan JY, Yip G, Lam YY, Liang YJ, Yu CM, Heart 2009 95 113 118 10.1136/hrt.2008.145698 18653570
28. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome. Van Bommel RJ, Borleffs CJ, Ypenburg C, Marsan NA, Delgado V, Bertini M, van der Wall EE, Schalij MJ, Bax JJ, Eur Heart J 2010 31 2783 90 10.1093/eurheartj/ehq252 20693544
29. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA, J Am Coll Cardiol 2009 53 355 60 10.1016/j.jacc.2008.09.043 19161886
30. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Tendera M, Anker SD, Blanc JJ, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ, Europace 2010 12 1526 36 20974767
31. The European cardiac resynchronization therapy survey. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J, Eur Heart J 2009 30 2450 60 10.1093/eurheartj/ehp359 19723694
32. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leán AR, Oshinski JN, Circulation 2010 121 1985 91 10.1161/CIRCULATIONAHA.109.910778 20421518
33. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ, Circulation 2010 122 985 92 10.1161/CIRCULATIONAHA.110.955039 20733097